Abstract

Male infertility is an important health concern that is expected to have a major genetic etiology. Although high-throughput sequencing has linked gene defects to more than 50% of rare and severe sperm anomalies, less than 20% of common and moderate forms are explained. We hypothesized that this low success rate could at least be partly due to oligogenic defects - the accumulation of several rare heterozygous variants in distinct, but functionally connected, genes. Here, we compared fertility and sperm parameters in male mice harboring one to four heterozygous truncating mutations of genes linked to multiple morphological anomalies of the flagellum (MMAF) syndrome. Results indicated progressively deteriorating sperm morphology and motility with increasing numbers of heterozygous mutations. This first evidence of oligogenic inheritance in failed spermatogenesis strongly suggests that oligogenic heterozygosity could explain a significant proportion of asthenoteratozoospermia cases. The findings presented pave the way to further studies in mice and man.

Data availability

Figure 5 - Source Data 1, Figure 6 - Source Data 1 and Figure 7 - Source Data 1 contain the numerical data used to generate the figures.

Article and author information

Author details

  1. Guillaume Martinez

    CHU Grenoble-Alpes, Grenoble, France
    For correspondence
    gmartinez@chu-grenoble.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7572-9096
  2. Charles Coutton

    CHU Grenoble-Alpes, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Corinne Loeuillet

    Institute for Advanced Biosciences, INSERM, CNRS, University Grenoble-Alpes, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Caroline Cazin

    CHU Grenoble-Alpes, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Jana Muroňová

    Institute for Advanced Biosciences, INSERM, CNRS, University Grenoble-Alpes, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Magalie Boguenet

    Institute for Advanced Biosciences, INSERM, CNRS, University Grenoble-Alpes, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  7. Emeline Lambert

    Institute for Advanced Biosciences, INSERM, CNRS, University Grenoble-Alpes, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  8. Magali Dhellemmes

    Institute for Advanced Biosciences, INSERM, CNRS, University Grenoble-Alpes, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  9. Geneviève Chevalier

    Institute for Advanced Biosciences, INSERM, CNRS, University Grenoble-Alpes, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  10. Jean-Pascal Hograindleur

    Institute for Advanced Biosciences, INSERM, CNRS, University Grenoble-Alpes, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  11. Charline Vilpreux

    Institute for Advanced Biosciences, INSERM, CNRS, University Grenoble-Alpes, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  12. Yasmine Neirijnck

    Department of Genetic Medicine and Development, University of Geneva Medical School, Genève, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  13. Zine Eddine Kherraf

    Institute for Advanced Biosciences, INSERM, CNRS, University Grenoble-Alpes, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  14. Jessica Escoffier

    Institute for Advanced Biosciences, INSERM, CNRS, University Grenoble-Alpes, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8166-5845
  15. Serge Nef

    Department of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  16. Pierre F Ray

    Institute for Advanced Biosciences, INSERM, CNRS, University Grenoble-Alpes, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  17. Christophe Arnoult

    Institute for Advanced Biosciences, INSERM, CNRS, University Grenoble-Alpes, Grenoble, France
    For correspondence
    christophe.arnoult@univ-grenoble-alpes.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3753-5901

Funding

Agence Nationale de la Recherche (ANR-19-CE17-0014)

  • Pierre F Ray
  • Christophe Arnoult

Agence Nationale de la Recherche (ANR-21-CE17-0007)

  • Guillaume Martinez
  • Charles Coutton

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal procedures were conducted according to a protocol approved by the local Ethics Committee (ComEth Grenoble No. 318), by the French government (ministry agreement number #7128 UHTA-U1209-CA), and by the Direction Générale de la Santé (DGS) for the State of Geneva.

Copyright

© 2022, Martinez et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 866
    views
  • 138
    downloads
  • 15
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Guillaume Martinez
  2. Charles Coutton
  3. Corinne Loeuillet
  4. Caroline Cazin
  5. Jana Muroňová
  6. Magalie Boguenet
  7. Emeline Lambert
  8. Magali Dhellemmes
  9. Geneviève Chevalier
  10. Jean-Pascal Hograindleur
  11. Charline Vilpreux
  12. Yasmine Neirijnck
  13. Zine Eddine Kherraf
  14. Jessica Escoffier
  15. Serge Nef
  16. Pierre F Ray
  17. Christophe Arnoult
(2022)
Oligogenic heterozygous inheritance of sperm abnormalities in mouse
eLife 11:e75373.
https://doi.org/10.7554/eLife.75373

Share this article

https://doi.org/10.7554/eLife.75373

Further reading

    1. Cell Biology
    2. Immunology and Inflammation
    Armando Montoya-Garcia, Idaira M Guerrero-Fonseca ... Michael Schnoor
    Research Article

    Arpin was discovered as an inhibitor of the Arp2/3 complex localized at the lamellipodial tip of fibroblasts, where it regulated migration steering. Recently, we showed that arpin stabilizes the epithelial barrier in an Arp2/3-dependent manner. However, the expression and functions of arpin in endothelial cells (EC) have not yet been described. Arpin mRNA and protein are expressed in EC and downregulated by pro-inflammatory cytokines. Arpin depletion in Human Umbilical Vein Endothelial Cells causes the formation of actomyosin stress fibers leading to increased permeability in an Arp2/3-independent manner. Instead, inhibitors of ROCK1 and ZIPK, kinases involved in the generation of stress fibers, normalize the loss-of-arpin effects on actin filaments and permeability. Arpin-deficient mice are viable but show a characteristic vascular phenotype in the lung including edema, microhemorrhage, and vascular congestion, increased F-actin levels, and vascular permeability. Our data show that, apart from being an Arp2/3 inhibitor, arpin is also a regulator of actomyosin contractility and endothelial barrier integrity.

    1. Cell Biology
    Parijat Biswas, Priyanka Roy ... Deepak Kumar Sinha
    Research Article

    The excessive cosolute densities in the intracellular fluid create a physicochemical condition called macromolecular crowding (MMC). Intracellular MMC entropically maintains the biochemical thermodynamic equilibria by favouring associative reactions while hindering transport processes. Rapid cell volume shrinkage during extracellular hypertonicity elevates the MMC and disrupts the equilibria, potentially ushering cell death. Consequently, cells actively counter the hypertonic stress through regulatory volume increase (RVI) and restore the MMC homeostasis. Here, we establish fluorescence anisotropy of EGFP as a reliable tool for studying cellular MMC and explore the spatiotemporal dynamics of MMC during cell volume instabilities under multiple conditions. Our studies reveal that the actin cytoskeleton enforces spatially varying MMC levels inside adhered cells. Within cell populations, MMC is uncorrelated with nuclear DNA content but anti-correlated with the cell spread area. Although different cell lines have statistically similar MMC distributions, their responses to extracellular hypertonicity vary. The intensity of the extracellular hypertonicity determines a cell's ability for RVI, which correlates with Nuclear Factor Kappa Beta (NFkB) activation. Pharmacological inhibition and knockdown experiments reveal that Tumour Necrosis Factor Receptor 1 (TNFR1) initiates the hypertonicity induced NFkB signalling and RVI. At severe hypertonicities, the elevated MMC amplifies cytoplasmic microviscosity and hinders Receptor Interacting Protein Kinase 1 (RIPK1) recruitment at the TNFR1 complex, incapacitating the TNFR1-NFkB signalling and consequently, RVI. Together, our studies unveil the involvement of TNFR1-NFkB signalling in modulating RVI and demonstrate the pivotal role of MMC in determining cellular osmoadaptability.